Primary Site >> Stomach Cancer

Gene >> TET1

  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2018
Ref: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
PMID: 22320381
Ref: Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
PMID: 23980508
Ref: Decreased expression of ten-eleven translocation 1 protein is associated with some clinicopathological features in gastric cancer.
PMID: 24507562
Ref: TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
PMID: 24804542
Ref: Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
PMID: 25098926
Ref: Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
PMID: 26462176
Ref: TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
PMID: 27121319
Ref: Ten-eleven translocation 1 dysfunction reduces 5-hydroxymethylcytosine expression levels in gastric cancer cells.
PMID: 29285192
Ref: MicroRNA4284 promotes gastric cancer tumorigenicity by targeting ten-eleven translocation 1.
PMID: 29512746
Ref: FANCA D1359Y mutation in a patient with gastric polyposis and cancer susceptibility: A case report and review of literature.
PMID: 30344425